AnalystsKeith Tapper
Keith Tapper's Stock Forecasts

Sectors:

Healthcare

Industries:

Biotechnology

Analyst Ranking

Bottom 24%

#3720 out of 4871 analysts

Average Return

-5.34%

Win Rate

50%3 out of 6

Risk vs Reward

Poor

Good

Keith Tapper's 5 best and worst ratings

Name / Ticker	Gain/Loss	Entry Price	Exit Price	Period	Rating
Neurogene IncNGNE	+55.83%	$10.89	$16.97	2025-04-14 - 2025-05-02	Buy
Taysha Gene Therapies IncTSHA	+19.17%	$2.17	$2.58	2024-06-27 - 2025-05-02	Buy
Neurogene IncNGNE	+10.70%	$15.33	$16.97	2024-11-20 - 2025-05-02	Buy

Keith Tapper Analyst Color

Get additional color on Keith Tapper's coverage of popular stocks

Keith Tapper's Stock Coverage

Name / Ticker	No. Ratings	Rating	Price Target	Upside/Downside	Action	Date
Neurogene IncNGNE	4	Buy	$16.00	-5.72%	Maintains	20 days ago
Taysha Gene Therapies IncTSHA	1	Buy	$5.00	+93.80%	Initiates Coverage On	10 months ago
Acadia Pharmaceuticals IncACAD	1	Buy	$31.00	+107.91%	Initiates Coverage On	10 months ago

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.